Sintredius oral solution is indicated for the treatment of:- Rheumatological disorders and connective tissue diseases such as: • rheumatoid arthritis (for primary chronic disease and maintenance therapy), • systemic lupus erythematosus (non-organ threatening disease), • mild-moderate juvenile dermatomyositis.- Severe or debilitating allergic conditions, not treatable in a conventional manner such as: • bronchial asthma in children, • bronchial asthma in adults (for maintenance therapy).- Sarcoidosis in children and for maintenance therapy in adults.- Acquired haemolytic anaemia (autoimmune, for maintenance therapy).